RMS LIFELINE, LLC.
Has been acquired by

Mergers & Acquisitions See more

WELLFOUNT CORP.

Has completed its $22,000,000 Debt and Equity financing
Debt Capital Markets See more
UPSTREAM REHABILITATION, LLC
Has been formed by management in collaboration with
Private Placements See more

FRESENIUS MEDICAL CARE

Through the divestiture of certain assets and the completion of a long-term product supply agreement, has formed
Mergers & Acquisitions See more

DOW CHEMICAL, INC

Through the “spin –off” of certain assets and sciences, and through the contribution of $20 million of capital from leading institutions, has formed

Mergers & Acquisitions See more


SORBENT THERAPEUTICS, INC.

Has issued $20,000,000

Series B Preferred Stock
Private Placements See more

ALINE AESTHETICS

a wholly owned subsidiary of

Has been acquired by
Mergers & Acquisitions See more


ORTHOCON, INC.

Has completed a comprehensive review of strategic & financial alternatives
Strategic Advisory See more


SMARTPILL, INC.
Has been acquired by

Mergers & Acquisitions See more

QUANTUM OPS, LLC

Has entered into an exclusive distribution agreement with

Strategic Advisory See more


INLIGHT, INC.

Has issued

$39,000,000


Series B Preferred Stock
Private Placements See more

 

PULSE SYSTEMS

Healthios has issued a fairness opinion in conjunction with the acquisition of Pulse Systems
Mergers & Acquisitions See more


ADVANTEDGE HEALTH SOLUTIONS

Has completed multiple strategic initiatives
Strategic Advisory See more


SXC HEALTH SOLUTIONS, INC.

Has expanded its management team and Board of Directors with the addition of several leaders with significant experience in the global healthcare industry
Strategic Advisory See more

iMEDICA, INC.

Has completed a strategic partnership with
Strategic Advisory See more


ING BARING

Has completed an investment in
Mergers & Acquisitions See more


BAXTER INTERNATIONAL, INC.

Has completed a strategic review of its dialysis business unit, including a market study of the Wearable Kidney Market and the Chronic Kidney Disease Market
Strategic Advisory See more

WELLDOC, INC.

Has completed a strategic partnership with
Strategic Advisory See more


STEADYMED, LTD

Has issued $10,000,000

Series B Preferred Stock
Private Placements See more


CALIBRA MEDICAL, INC.

Has issued $10,000,000

Senior Subordinated Debt
Debt Capital Markets See more


IRX Therapeutics

Has completed a round of financing
Private Placements See more

ENVISIA THERAPEUTICS, INC.

Has completed a $25 ,000,000 Series A Financing in conjunction with the “spin –off” of certain assets and sciences from Liquidia
Private Placements See more

BAYER PLASMA, GmBH


An operating division of

Has been acquired by

Cerberus, LLC
Mergers & Acquisitions See more

ALPHA THERAPEUTICS, INC.

An operating division of
Has been acquired by
Mergers & Acquisitions See more


PINNACLE BIOLOGICS, INC.

Has completed its $6,000,000 Series A financing
Private Placements See more


SORBENT THERAPEUTICS, INC.

Has completed its spinout from Dow Chemical
Strategic Advisory See more

NOVALAR PHARMACEUTICALS, INC.
Has been acquired by


$65,000,000
Mergers & Acquisitions See more

LIQUIDIA TECHNOLOGIES, INC.

Has completed a global collaboration with

Strategic Advisory See more


INNFOCUS, LLC


Has completed a structured financing with
Mergers & Acquisitions See more


BOSTON SCIENTIFIC, INC.


Has completed a strategic review of its endoscopy business unit leading to its decision to optimize strategic alternatives through a tax-efficient “spin-off”
Strategic Advisory See more


CARDIOSOUTIONS, INC.


Has completed its $15,000,000 Series B financing led by
Private Placements See more



VERAX BIOMEDICAL, INC.


Has entered a Worldwide Commercialization Partnership with
Strategic Advisory See more


DEERAC FLUIDICS, INC.

Has been acquired by
Mergers & Acquisitions See more

CLAROS DIAGNOSTICS, INC.

Has been acquired by

Mergers & Acquisitions See more


BIOMERIX, INC.

Has completed a Strategic Investment by

Strategic Advisory See more


MIACOM DIAGNOSTICS

Has completed its equity financing from
Private Placements See more


CRITICAL PERFUSION, INC.

Has entered into a co-development agreement with

 

Strategic Advisory See more
CLEARCOUNT MEDICAL SOLUTIONS, INC.
Has licensed various IP to
Mergers & Acquisitions See more


NOVADAQ TECHNOLOGIES, INC.

Has completed a review of various divestiture and strategic financing alternatives
Private Placements See more

PATHWAY MEDICAL TECHNOLOGIES, INC.

Has completed multiple strategic sales and  marketing initiatives
Mergers & Acquisitions See more

BIOSPHERE MEDICAL, INC.


Has completed multiple strategic initiatives
Strategic Advisory See more

TRIREME MEDICAL, INC.

Has completed its $17,000,000 Series D financing

THE UNDERSIGNED ACTED AS EXCLUSIVE ADVISOR TO TRIREME
Private Placements See more
TRIREME MEDICAL, INC.
Has entered into an exclusive distribution agreement with

Strategic Advisory See more



CHEETAH MEDICAL LTD.
Has completed its $20,000,000 Series B financing

THE UNDERSIGNED ACTED AS  EXCLUSIVE
ADVISOR TO CHEETAH
Private Placements See more

BRONCUS TECHNOLOGIES, INC.
Has sold certain emphysema assets to


THE UNDERSIGNED ACTED AS EXCULSIVE
ADVISOR TO BRONCUS
Mergers & Acquisitions See more

CALIBRA MEDICAL, INC
Has been acquired by

Mergers & Acquisitions See more


WELLDOC, INC.

Has issued $10,000,000 Series A Preferred Stock
Private Placements See more


WELLDOC, INC.

Has issued $10,000,000 Series B Preferred Stock
Private Placements See more
INSPIRATION BIOPHARMACEUTICALS, INC.

Completed a strategic partnership with 

$259,000,000

Strategic Advisory See more

Nanomix, Inc.


NANOMIX, INC.

Has completed its $12,000,000 Equity financing by strategic and financial investors
Private Placements See more
Kalon

FDBU (a Fujifilm subsidiary) acquires 49% of the total membership interests in Kalon

Fujifilm
Mergers & Acquisitions See more


CORIUM INTERNATIONAL, INC.

Has issued $35 million in Interest-Bearing High Yield Securities
Debt Capital Markets See more

SYNCARDIA SYSTEMS, INC.

SYNCARDIA SYSTEMS, INC.
Has completed its $11,000,000
Series D financing
THE UNDERSIGNED ACTED AS ADVISOR TO SYNCARDIA

 

Private Placements See more